TrialClinical and translational science2019

PF-04447943, a Phosphodiesterase 9A Inhibitor, in Stable Sickle Cell Disease Patients: A Phase Ib Randomized, Placebo-Controlled Study.

Robert J Charnigo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.